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Abstract 
Non-tuberculous mycobacteria (NTM) are all the other mycobacteria which can cause pulmonary disease resembling 
tuberculosis, lymphadenitis, skin disease, or disseminated disease. The antimycobacterial activity of methanol, n-hexane and 
dichloromethane extracts of Zingiber officinale Rosc. (Ginger) rhizome and extract of Curcuma longa Linn. (Turmeric) were 
evaluated against four (4) species of nontuberculous Mycobacteria: Mycobacterium abscessus, Mycobacterium smegmatis 
ATCC 19420, Mycobacterium phlei ATCC 19240 and Mycobacterium fortuitum 684. Susceptibility tests were carried out 
using the agar well diffusion techniques while agar dilution method was used to determine the minimum inhibitory 
concentration (MIC). Bactericidal activities of bioactive extracts were evaluated by the viable counting techniques. 
Dichloromethane extract of Zingiber officinale showed the highest inhibition zone of 16 ± 0.5 and 22 ± 0.00 mm for M. 
abscessus and M. fortuitum ATCC 684 respectively; and the MIC and MBC for both species of organism were 6.25 mg/mL 
and 75 mg/mL. The n-hexane and methanol fractions of Zingiber officinale had no activity against tested Mycobacteria 
species. Methanol and n-hexane extracts of Curcuma longa both showed the highest inhibition zone of 16 ± 0.5 and 20 ± 0.0 
mm respectively for M. abscessus while the MIC and MBC for both extracts were 25 mg/mL and 75 mg/mL respectively. The 
kill kinetics of the two plants against susceptible test organisms indicated a dose-dependent bactericidal activity, with decline 
in population (> 50%) within 4 hours of exposure followed by a total kill (100%) of the population at 8 hours exposure time at 
doses equivalent to 4 x MIC and 8 x MIC. Thus, it is concluded that this plants may contain compounds with therapeutic 
activity that could be used in treatment of diseases originating from non-tuberculous mycobacteria infection. 
Keyword: Zingiber officinale Rosc. (Ginger), Curcuma longa Linn. (Turmeric), Nontuberculous 
Mycobacteria, Antimycobacterial activity, In vitro  
 
1. Introduction 
Nontuberculous mycobacteria (NTM) species, also known as environmental mycobacteria, atypical mycobacteria (Griffith et 
al., 2007) and mycobacteria other than tuberculosis (MOTT), are mycobacteria which do not cause tuberculosis or Hansen's 
disease (also known as leprosy). Nontuberculous mycobacteria are widely distributed in the environment, particularly in wet 
soil, marshland, streams, rivers and estuaries. Different species of NTM prefer different types of environment (Grange, 2007). 
Human disease is believed to be acquired from environmental exposures, and unlike tuberculosis and leprosy, there has been 
no evidence of animal-to-human or human-to-human transmission of NTM, hence the alternative label "environmental 
bacteria" (ATS, 1997). Nontuberculous mycobacteria diseases have been seen in most industrialized countries, where 
incidence rates vary from 1.0 to 1.8 cases per 100,000 persons. Recent studies, including one done in Ontario, Canada, 
suggest that incidence is much higher (Marras et al, 2013). Pulmonary NTM is estimated by some experts in the field to be at 
least ten times more common than TB in the U.S., with at least 150,000 cases per year (Griffith et al., 2007). Most NTM 
disease cases involve the species Mycobacterium avium complex (MAC), M. abscessus, M. fortuitum and M. kansasii. 
Mycobacterium abscessus is being seen with increasing frequency and is particularly difficult to treat (ATS, 1997). Rapidly 
growing NTMs are implicated in catheter infections, post-LASIK, skin and soft tissue (especially post-cosmetic surgery) and 
pulmonary infections (Nash et al., 2009). Nontuberculous mycobacteria have been observed to cause pulmonary disease that 
is very similar to Mycobacterium tuberculosis especially when such cases showed no clinical improvement to conventional 
anti-tuberculosis (TB) treatment in addition to isolation of the NTM organism during culture. The diagnosis of NTM is not 
possible using acid fast bacillus (AFB) microscopy which is the main stay of TB diagnosis in several developing countries. As 
a result, many of the pulmonary diseases caused by NTM are not identified but rather treated with conventional anti-TB 
treatment which eventually fails because majority of the NTM are resistant to conventional anti-TB treatment (Park et al., 
2010). The prevalence of NTM and NTM-associated hospitalization has been on the increase in several industrialized 
countries (Gopinath et al., 2008). Some of the countries report a NTM prevalence rate as high as 50% among cultured 
mycobacteria (Park et al., 2010). However, there is paucity of data from developing countries largely due to the lack of 
laboratory infrastructure for culture and specie identification. The increasing frequency of pathogenic NTM has become 
important especially with the advent of HIV/AIDS. It has been observed that HIV/AIDS patients with severe 
immunosuppression are at risk of NTM which can cause localized or disseminated infections as in Mycobacterium 
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intracellulare (Park et al., 2010). The main reason for eradication failure can be NTM resistance to some of the antibiotics 
used for treatment. Also chemical drugs have side effects such as diarrhoea and colitis. Therefore it is necessary to introduce 
alternative remedial regimens. One of these resources is medicinal plants, the therapeutic properties of some of which have 
been recognized in traditional medicine. Most people have positive attitude toward natural products due to their natural origin 
and lesser toxicity (Naik et al., 2003). Study of anti-Mycobacterial effects of these plants, especially those that are 
traditionally used for pulmonary infections are important. The present study was carried out to evaluate in vitro anti-
Mycobacterial activity of some spices of medicinal plants [Zingiber officinale Rosc. and Curcuma longa Linn. 
(Zingiberaceae)] that have been traditionally used  in folk medicine. 
 
2. Materials and Methods 
2.1 Plant collection, extraction, and preparation of extracts 
Edible rhizome of Zingiber officinale Rosc (Ginger) and Curcuma longa Linn. (Turmeric) were purchased from Bodija 
Market, Ibadan, Oyo State, South–West of Nigeria; between the months of April 2012 and May 2012. They were identified 
and authenticated by a botanist at the Department of Botany and Microbiology, University of Ibadan, Oyo State. Voucher 
specimens were deposited at the Herbarium for reference and plant samples were assigned voucher specimen number UIH 
22362 for Z. officinale and UIH 22363 for C. longa. The rhizomes were dusted and air dried at room temperature for 5 to 7 
weeks and then grounded to coarse powder using a dry electric mill (Moulinex, France). The pulverized plants material (1.8 
kg of Z. officinale) and (2.3 kg of C. longa) were subjected to exhaustive Soxhlet extraction with n-hexane, dichloromethane 
and methanol in succession. Extracts were collected, dried under reduced pressure (lyophilized) at International Institute of 
Tropical Agriculture (IITA), Ibadan, Oyo State, Nigeria. The lyophilized extracts were weighed and stored at 4°C before use. 
Stock solutions of lyophilized extracts were reconstituted in 20% ethanol with final concentrations of 20 to 100 mg/mL 
prepared for the initial screening. Concentrations in the range of 6.25 and 200 mg/mL were also prepared to determine the 
minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the bioactive extracts. 
 
2.2 Antimicrobial Agents 
The chemotherapeutic agents used in the test as positive control was Rifampicin (Nicholas Laboratories Limited, England), 
while the negative control was 20% Ethanol. 
2.3 Phytochemical screening 
Phytochemical screening was carried out to detect the presence of secondary metabolites such as anthraquinones, 
tannins, saponins, alkaloids, and phenol using methods described by Harborne (1991). 
 
2.4 Strains of Nontuberculous Mycobacteria (NTM) 
Four (4) non-tuberculous mycobacteria isolates used for this investigation were Mycobacterium abscessus, Mycobacterium 
smegmatis ATCC 19420, Mycobacterium phlei ATCC 19240 and Mycobacterium fortuitum 684. 
 
2.5 Susceptibility testing 
Susceptibility was determined using the agar cup diffusion technique. A 0.1 mL aliquot of logarithmic phase broth culture of 
each bacterium (optical density equivalent to 107-108 cfu/mL) was used to seed sterile molten Mueller-Hinton agar (Oxoid) 
medium maintained at 45°C  and supplemented with 5% sterile horse blood. The seeded plates were allowed to dry in a sterile 
incubator at 37°C for 20 min. A standard cork borer (8 mm diameter) was used to cut uniform wells on the surface of the agar, 
into which was added 100 µL of the test extracts reconstituted in 20% ethanol. A pre-incubation diffusion of the extracts into 
the seeded medium was allowed for 1 hr. Plates were incubated at 37°C for 2-3 days after which diameters of zones of 
inhibition (mm) were measured. 20% ethanol was included in each plate as a solvent control while Rifampicin (10 µg/mL) 
was used as positive control. This method is similar to previous published procedures (Adeniyi et al., 2006). 
 
2.6 Determination of minimum inhibitory concentrations 
Minimum inhibitory concentrations (MIC) of bioactive extracts were determined by a modification of standard agar dilution 
method procedures as previously described (Adeniyi et al., 2009). Extracts were tested at various concentrations. The positive 
control antibiotic included was rifampicin. The MICs were determined after 2-3 days of incubation at 37°C. The MIC was 
regarded as the lowest concentration that prevented visible growth of test organisms from a duplicate experiment. 
 
2.7 Determination of minimum bactericidal concentrations 
Minimum bactericidal concentration (MBC) of active plant extracts was determined by a modification of the method of 
Aibinu et al., (2007). To a 0.5 mL extract at different concentration as used in the MIC assay that showed no visible growth 
on the agar plates, was added 0.5 mL of test organism in a tube. These were incubated at 37oC for about 24-48 hours. Samples 
were streaked out from the tubes on the surface of sterile extract-free Mueller-Hinton agar (Oxoid) medium supplemented 
with 5% sterile horse blood in Petri dishes to determine the minimum concentration of the extract required to kill the 
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organisms. These concentrations were indicated by the inability of the organisms to grow on transfer to the extract-free agar. 
The lowest concentration that prevented bacterial growth after 48 hr of incubation was recorded as the minimum bactericidal 
concentration (MBC). The entire tests were carried out in duplicates to ensure accuracy. Agar plates without extracts and 
another agar plate without any inoculated organism were also incubated to serve as organism and extract control plates 
respectively. Minimum bactericidal concentration (MBC) was also determined for the drug control. 
 
2.8 Determination of bactericidal activity of the methanol extract of Z. officinale and C. longa 
The viable counting technique was employed for this purpose (Lajubutu et al., 1995). An overnight broth culture in 4.5 mL of 
Tryptic Soy broth inoculated in a static growth condition of each organism was made. Mycobacterium fortuitum ATCC 684 
and M. abscessus were used for this experiment. A 0.5 mL of each culture was sub-cultured into a warm (37°C) 4.5 mL 
Tryptic Soy broth and incubated for 90 min using a Gallenkamp orbital incubator to give a logarithmic phase culture. A 0.1 
mL of the logarithmic phase culture was then inoculated into a warm 4.9 mL of Tryptic Soy broth containing the test 
compound to give 1 in 50 dilution of the culture (equivalent to approximately 1×107 colony forming units) and the required 
concentration of the extract. An appropriate quantity of the test sample (extract-culture mixture) was withdrawn immediately, 
diluted out in Tryptic Soy broth and 0.2 mL of 1:1000 dilution plated on an oven dried Mueller-Hinton agar supplemented 
with 5% sterile horse blood in Petri dishes to give control time 0 minute count. Samples were taken at 30 min, 1, 2, 4, 8 and 
24 h. The procedure was carried out in duplicate. Plates were incubated at 37°C for 24 h before counting the colonies. Control 
plates for negative and positive controls were also incubated. The number of colony forming unit (cfu) were counted after the 
period of incubation. The numbers of surviving bacterial cells per ml were calculated by taking into consideration the dilution 
factor and the volume of the inoculum. All the procedure was repeated for MIC, 2 × MIC, 4 × MIC and 8 × MIC. A graph of 
percentage viable count against time in hour was plotted to show the rate of kill of the test organisms after duplicate 
experiments. 
 
3. Results and Discussion 
The anti-Mycobacteria activity of extracts of Zingiber officinale Rosc.(Ginger) and Curcuma longa Linn. (Turmeric) 
rhizomes on nontuberculous mycobacteria were evaluated. The yield and macroscopic characteristics of Zingiber officinale 
Rosc. (Ginger) and Curcuma longa Linn. (Turmeric) rhizomes are presented in Table 1. The percentage yield of the methanol 
extracts of the dried rhizome of Zingiber officinale Rosc. (Ginger) and the dried rhizome of Curcuma longa Linn. (turmeric) 
was highest. This is contrary to the report of Cowan (1999) that ranked methanol second next to dichloromethane in terms of 
yield in extraction of plant active components. Phytochemical screening for secondary metabolites revealed the presence of 
high concentration of alkaloids and tannins as well as a moderate amount of flavonoids in Zingiber officinale Rosc. (Ginger) 
rhizome while saponins, anthraquinones and phenols were not detected. High concentrations of tannins and anthraquinones 
and a moderate amount of saponins and phenols were present in Curcuma longa Linn. (Turmeric) rhizome. Alkaloids and 
flavonoids were absent. These various plant metabolites have earlier been reported to possess medicinal, antimicrobial and 
physiological activities (Shula & Singh, 2007; Surh et al., 1998; Surh 2002). The presence of these secondary metabolites 
could be the reasons for the observed antimicrobial activities of these plants. Many phytomedicines exert their effects through 
the additive or synergistic action of several compounds acting at a single or multiple target sites associated with physiological 
process (Tyler, 1999). The results of the anti-Mycobacteria screening of the extracts by the use of agar well diffusion 
technique are presented in Tables 2. The zone of inhibition as presented in Table 2, clearly indicated that dichloromethane 
extract of Zingiber officinale Rosc. (ginger) had the highest inhibitory activity as indicated for Mycobacterium fortuitum 
ATCC 684 and M. abscessus with zones of inhibition of 22 ±0.0 mm and 16 ±0.5 mm respectively at a concentration of 100 
mg/mL. Mycobacterium abscessus was susceptible to methanol and n-hexane extracts of Curcuma longa Linn. (turmeric) as 
well as the dichloromethane extract of Zingiber officinale Rosc. (ginger) at the test concentrations. Mycobacterium smegmatis 
ATCC 19420 and M. phlei ATCC 19240 were not susceptible to extracts of both ginger and turmeric. Dichloromethane 
extract of Curcuma longa Linn. (turmeric) as well as methanol and n-hexane extracts Zingiber officinale Rosc. (ginger) had 
no antibacterial activity on the test organisms, and so the results were not tabulated.  The factors responsible for the high 
susceptibility of M. fortuitum ATCC 684 and M. abscessus to ginger extracts are not exactly known but may be attributed to 
the secondary metabolites (inhibins) and phytochemicals (gingerol and shagelol, flavonoids) isolated from ginger (Stewart et 
al., 1991). The results obtained in this study agree with that of Ficker et al., (2003), Grange and Davey (1990) and Zahra et 
al., (2009). 
 
The minimum inhibitory concentration (MICs) and minimum bactericidal concentration (MBCs) of the bioactive extracts 
against the susceptible non-tuberculous mycobacteria species are summarized in Table 3. The MIC, MBC and kill kinetics of 
methanol and n-hexane extracts of Curcuma longa Linn. (turmeric); and dichloromethane extracts of Zingiber officinale Rosc. 
(ginger) rhizomes were determined using M. fortuitum ATCC 684 and M. abscessus. The MIC values confirmed the existence 
of inhibitory effects of Zingiber officinale Rosc. (ginger) and Curcuma longa Linn. (turmeric) dried rhizome with MIC values 
ranging from 6.25 mg/mL to 25 mg/mL for both extracts on selected susceptible species except M. smegmatis ATCC 19420 
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and M. phlei ATCC 19240 which were not susceptible to the extracts at the tested concentrations. The MICs of 
dichloromethane extract of Zingiber officinale Rosc. (Ginger) on the entire test Mycobacterium species in Table 3 were 
observed to be lower than that of Curcuma longa Linn. (turmeric) extracts. The observed results revealed the presence of 
more potent antibacterial compounds in Zingiber officinale Rosc. (Ginger) than in Curcuma longa Linn. (turmeric). This may 
be attributed to the fact that the two plants though in the same family belong to different genus and also possess different 
phytochemical components to which the observed anti-mycobacterial activity had been attributed. 
 
The time-kill study of the extracts of Zingiber officinale Rosc. (Ginger) and Curcuma longa Linn. (Turmeric) dried rhizome 
on M. fortuitum ATCC 684 and M. abscessus as shown in figures 1- 4 revealed a dose-dependent bactericidal activity, with 
decline in population after 4 hours of exposure to the extracts at doses equivalent to MIC, 2 x MIC, 4 x MIC and 8 x MIC 
followed by a total kill of the population at 8 hours of exposure to concentrations equivalent to 4 x MIC and 8 x MIC, and at 
24 hours of exposure to concentrations equivalent to MIC and 2 x MIC. The higher kill rate by the extract at higher 
concentration (8 x MIC) observed, suggested resistance of the Mycobacterium species to lower concentrations. This 
observation is supported by the reports of Yang et al., (2003) who noted that nontuberculous mycobacteria are usually more 
resistant to antimycobacterial agents. This was also observed during the susceptibility testing where the test organisms were 
resistant to low concentration (5 µg/mL) of Rifampicin. The bactericidal activity was observed to be dependent on time and 
dose/concentration as the percentage reduction in viable count of surviving population increased with increase in exposure 
time and concentration of the extracts. This is similar to previous kinetics study (Funatogawa et al., 2004). Nontuberculous 
Mycobacteria infection (NTM) is said to be opportunistic in nature, infecting both humans and animals. Infection is acquired 
by consuming water, inhaling aerosols, or through penetrating injuries of the skin. Three principal classes of disease due to 
NTM are lymphadenitis, post-inoculation lesions and pulmonary disease. There have been few major controlled clinical trials 
of the therapy of pulmonary disease due to NTMs. Those that have been conducted have been based on triple regimens of 
rifampicin, isoniazid, and ethambutol (BTS 2000). However, these regimens may have side effects, poor compliance, and 
antibiotic resistance. Therefore, alternative antimicrobial agents sourced from natural products such as Zingiber officinale 
Rosc. (ginger) and Curcuma longa Linn. (turmeric) rhizomes with fewer disadvantages are necessary for the treatment of 
nontuberculous Mycobacteria infection in developing countries, especially as they are edible and readily available. 
 
 
 
Table 1: Yield and Macroscopic Characteristics of Zingiber officinale Rosc. (Ginger) and Curcuma longa Linn. 
              (Turmeric) 
Name of Plant Plant Part Solvent Used Weight of  
sample 
extracted       
      (g) 
Yield of 
extract         
     (g) 
Percentage 
yield of extract     
         (%) 
Macroscopic 
Characteristics of 
extract 
Zingiber officinale 
Rosc. (Ginger) 
Rhizome 
 
Methanol 2290.92 107.60 4.70 Dark-brown solid 
Dichloro-
methane 
2290.92 37.00 
 
1.62 Black Semi-solid 
n-Hexane 2290.92 32.86 
 
1.43 Dark-brown semi 
solid 
Curcuma longa 
Linn. (Turmeric) 
Rhizome 
 
Methanol 1819.20 70.40 3.87 Brown coloured solid 
Dichloro-
methane 
1819.20 57.73 
 
3.17 Dark-brown solid 
n-Hexane 1819.20 66.97 3.68 
 
Reddish-brown semi-
solid 
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Table 2: Antimicrobial susceptibility of Mycobacteria species to lyophilized extracts of Zingiber officinale Rosc. 
               (Ginger) and Curcuma longa Linn. (Turmeric). Mean diameter of zone of inhibition (mm) ± SEM.   
 
 Methanol extract of 
Curcuma longa (Turmeric) 
(mg/mL) 
n-Hexane extract of 
Curcuma longa (Turmeric) 
Dichloromethane extract of 
Z. officinale   (Ginger) 
(mg/mL) 
Rifampicin 
(µg/mL) 
Mycobacteria 
species 
20  
 
100  
 
20  
 
 
100  
 
20  
 
100  
 
10 
 
M. fortuitum 
ATCC 684  
- - - - 19±0.0 22±0.0 24± 0.5 
M. smegmatis 
ATCC 19420 
- - - - - - 26± 0.0 
M. phlei ATCC 
19240 
- - - - - - 30± 0.0 
M. abscessus 15±0.5 16±0.5 15±0.0 20±0.0 15±0.0 16±0.5 28± 0.0 
*Result is average of duplicate experiment; - = No activity (Resistant), Diameter of cork borer = 8 mm 
 
 
 
 
 
 
 
Table 3: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of lyophilized 
                methanol extracts of Zingiber officinale  Rosc. (Ginger) and Curcuma longa Linn. (Turmeric) on 
               susceptible Mycobacteria species 
 
  Methanol extract of C. 
longa (mg/mL) 
n-Hexane extract of C. 
longa (mg/mL) 
Dichloromethane extract 
of Z. officinale (mg/mL) 
Rifampicin (µg/mL) 
 MIC MBC MIC MBC MIC MBC MIC MBC 
M. fortuitum ATCC 
684 
 
ND 
 
ND ND ND 6.25 75 6.25 6.25 
M. abscessus 25 
 
75 25 75 6.25 75 6.25 6.25 
Note: Result is average of duplicate experiment; ND: Not determined 
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Fig. 1: Percentage viable count (Survival) vs Time (hr) of dichloromethane extract of Zingiber officinale Rosc. 
             (Ginger) on Mycobacterium fortuitum ATCC 684 showing the rate of kill of the organism at the different 
            concentrations of the extract.  
 
Fig. 2: Percentage viable count (Survival) vs Time (hr) of dichloromethane extract of Zingiber officinale Rosc. (Ginger) on 
Mycobacterium abscessus showing the rate of kill of the organism at the different concentrations of the extract. 
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Fig. 3: Percentage viable count (Survival) vs Time (hr) of n-hexane extract of Curcuma longa Linn. (Turmeric) on 
Mycobacterium abscessus showing the rate of kill of the organism at the different concentrations of the   extract. 
 
 
Fig. 4: Percentage viable count (Survival) vs Time (hr) of methanol extract of Curcuma longa Linn. (Turmeric) 
on Mycobacterium abscessus showing the rate of kill of the organism at the different concentrations of the extract 
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4. Conclusion 
The antimycobacterial activities of Zingiber officinale Rosc. (ginger) and Curcuma longa Linn. (turmeric) were investigated 
on selected nontuberculous mycobacteria and the study revealed the antimycobacterial effects of ginger and turmeric on some 
of the test organisms. Although the active components in the ginger and turmeric samples were not isolated and characterized 
in this study, the results showed that the plant samples tested exhibited a high degree of antimycobacterial activity on the 
susceptible test microbes. It can be concluded that these plants possess bioactive compounds with good antimycobacterial 
properties that may be of therapeutic importance in the treatment of infections caused by the test organisms. 
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